Loading company…
StarRise Biotech develops radiopharmaceuticals for cancer diagnosis and treatment.
StarRise Biotech researches and commercializes radiopharmaceuticals for tumor diagnosis and treatment, including radioligand therapy. Founded in 2025 and based in Chengdu, China, it raised Angel funding in August 2025 co-invested by BIO-TOWN Capital and Shanghai Fosun Pharmaceutical (Group).
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in